Signity Pharmaceuticals

Pune, India Founded: 2010 • Age: 16 yrs
Manufactures high-end anti-infectives, nutraceuticals, and life-saving drugs for global markets.

About Signity Pharmaceuticals

Signity Pharmaceuticals is a Healthcare company based in Pune (India) founded in 2010 by Bhupendra Bhaskar Marliwar, Shridhar Diwakar Dhavle, and Vishal Mulani. It manufactures high-end anti-infectives, nutraceuticals, and life-saving drugs for global markets. It operates on a B2B and Export Distribution model. The company has 45 employees. Its chief executive, as recorded, is Vishal Mulani. Its website signitypharma.com draws about 681 thousand monthly visits. Its Indian entity Signity Pharmaceuticals Private Limited reported revenue of β‚Ή15.55 Cr. Signity Pharmaceuticals offers products and services including Anti-Infective Range, Gastro/Hepato Care Range, Ortho Care Range, Respiratory Range, and Nutraceutical Formulations. Its focus areas include Pharmaceuticals, Anti-Infectives, High-End Drugs and Nutraceuticals.

Company details

Signity Pharmaceuticals Pvt. Ltd. is a pharmaceutical company based in India that focuses on developing and supplying high-end anti-infectives, life-saving drugs, hepatoprotective formulations, and unique nutraceuticals. They operate through innovative drug development led by experienced experts, exporting products to Europe, America, and Southeast Asia. Activities include participating in events, awards, and foundation celebrations, serving healthcare needs with ethical standards and patented innovations.

  • Headquarters Pune, India
  • Employees 45
  • Founders Bhupendra Bhaskar Marliwar, Shridhar Diwakar Dhavle, Vishal Mulani
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website signitypharma.com
  • Social Facebook
  • Legal Name Signity Pharmaceuticals Private Limited
  • Date of Incorporation 13 Sep, 2010
  • Jurisdiction Nagpur, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹15.55 Cr

    FY 2025 · +7% YoY

  • Net Profit
    ₹40.1 Lakh

    FY 2025 · 3% margin

  • EBITDA
    ₹84.1 Lakh

    FY 2025 · 5% margin

  • Employee Count
    45

Products & Services of Signity Pharmaceuticals

Signity Pharmaceuticals offers a comprehensive portfolio of products and services, including Anti-Infective Range, Gastro/Hepato Care Range, Ortho Care Range, Respiratory Range, and Nutraceutical Formulations.

Anti-Infective Range
Pharmaceuticals

Formulations for treating bacterial and viral infections effectively.

Gastro/Hepato Care Range
Pharmaceuticals

Drugs for liver and digestive health management.

Ortho Care Range
Pharmaceuticals

Specialty formulations for orthopedic pain and conditions.

Respiratory Range
Pharmaceuticals

Treatments for respiratory illnesses and related issues.

Nutraceutical Formulations
Nutraceuticals

Unique supplements designed for health enhancement.

Board of directors of Signity Pharmaceuticals Private Limited (Signity Pharmaceuticals)

Signity Pharmaceuticals Private Limited is the primary company behind Signity Pharmaceuticals. The board of Signity Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Bhupendra Bhaskar Marliwar, appointed in 2010. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Bhupendra Bhaskar Marliwar
DIN 03055079
Director13 Sep 201016 yrs 1 moSignity Pharmaceuticals Private Limited
Saiye Bhupendra Marliwar
DIN 11025702
Additional Director19 Jul 20251 yr 3 moSignity Pharmaceuticals Private Limited
Bhraman Bhaskar Marliwar
DIN 07784040
Additional Director19 Jul 20251 yr 3 moSignity Pharmaceuticals Private Limited
Bhushan Bhaskar Marliwar
DIN 07775474
Additional Director22 Aug 20251 yr 2 moSignity Pharmaceuticals Private Limited

People of Signity Pharmaceuticals

3 people are tracked at Signity Pharmaceuticals (3 in leadership); the tracked headcount is 45.

NameRoleGroup
Co-FounderLeadership
Co-FounderLeadership
Vishal Mulani
Co-Founder, CEOLeadership
Premium access

Complete people profiles for Signity Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Signity Pharmaceuticals

Figures of Signity Pharmaceuticals Private Limited, the primary company behind Signity Pharmaceuticals, for FY 2025. Revenue was ₹15.55 Cr (+7% year on year). Net profit was ₹40.1 Lakh (3% margin). EBITDA was ₹84.1 Lakh (5% margin). Revenue has grown at a compounded annual rate of +13% over three years and +17% over five years.

  • ₹15.55 CrRevenue · FY 2025 · +7% YoY
  • ₹40.1 LakhNet profit · 3% margin
  • ₹84.1 LakhEBITDA · 5% margin
  • ₹64.9 LakhPaid-up capital
  • 45Employees (provident fund records)
  • +13%Revenue CAGR, 3 years
  • +17%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Signity Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Signity Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Signity Pharmaceuticals

The website of Signity Pharmaceuticals (signitypharma.com) receives about 680.7K visits a month.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with Signity Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Signity Pharmaceuticals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Signity Pharmaceuticals

Premium access

Complete news archive for Signity Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Signity Pharmaceuticals

Signity Pharmaceuticals was founded in 2010.

Signity Pharmaceuticals is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Vishal Mulani is the CEO of Signity Pharmaceuticals, as recorded in our data. They have also founded this company.

Signity Pharmaceuticals has 45 employees.

The primary company behind Signity Pharmaceuticals, Signity Pharmaceuticals Private Limited, reported revenue of β‚Ή15.55 Cr for FY 2025, up 7% year on year.

Signity Pharmaceuticals Pvt. Ltd. is a pharmaceutical company based in India that focuses on developing and supplying high-end anti-infectives, life-saving drugs, hepatoprotective formulations, and unique nutraceuticals. They operate through innovative drug development led by experienced experts, exporting products to Europe, America, and Southeast Asia. Activities include participating in events, awards, and foundation celebrations, serving healthcare needs with ethical standards and patented innovations.

Signity Pharmaceuticals offers Anti-Infective Range, Gastro/Hepato Care Range, Ortho Care Range, Respiratory Range, and Nutraceutical Formulations.

Signity Pharmaceuticals operates through Signity Pharmaceuticals Private Limited.

The legal entities of Signity Pharmaceuticals currently have 4 directors, including Bhupendra Bhaskar Marliwar, Saiye Bhupendra Marliwar, Bhraman Bhaskar Marliwar and others.

The website of Signity Pharmaceuticals receives about 681 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available